课题基金 / 基金详情

Studies on Acceptability of Vaginal Microbicides

Studies on Acceptability of Vaginal Microbicides
阴道杀菌剂的可接受性研究
批准号:
6656868
负责人:
GITA RAMJEE
金额:
$22.0万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-29 至 2004-08-31

项目摘要

项目成果

GITA RAMJEE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the applicant's description): The explosive nature of the South African epidemic calls for urgent measures for HIV prevention in the country. The multidisciplinary group of researchers from two National (Johannesburg and Durban) and two International sites (UK and USA) propose a series of innovative studies of determining acceptability of microbicides. The extensive experience of the applicants in conducting clinical, behavioral, pharmaceutical, social, biostatistics, epidemiological and health systems research places them in a unique position to conduct a wide range of studies to assess acceptability. The research objectives will be addressed in five phases with a combination of qualitative and quantitative methods. Objectives include: 1. Retrospective assessment of factors associated with continued use of a vaginal microbicide among sex workers who had participated in a Phase III trial; 2. Development of a standardized tool for measuring acceptability; 3. Prospective assessment of factors associated with continued use of a vaginal microbicide in a non-clinical setting (if appropriate products are available); 4. Ascertainment of acceptable product characteristics and delivery mechanisms for microbicides using inert products and application of these findings to assessing the acceptability of several products currently in development; and 5. Identification of facilitators and barriers to the introduction and use of microbicides among health care providers and potential users in South Africa.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
South Africa MRC HIV Prevention Trials Unit
South Africa MRC HIV Prevention Trials Unit
South Africa MRC HIV Prevention Trials Unit
South African Medical Research Council Clinical Trials Unit (MRC CTU)
海外基金